Back to Search Start Over

The integrated care pathway for melanoma: the Istituto Dermopatico dell’Immacolata experience in Rome: Il percorso diagnostico terapeutico e assistenziale nella gestione del paziente con melanoma cutaneo: l’esperienza dell’IDI di Roma

Authors :
Ricci, Francesco
Caggiati, Alessio
Ziparo, Vincenzo
Elia, Maurizio
Russo, Giandomenico
D'Atri, Stefania
Failla, Cristina Maria
Panebianco, Annarita
Annessi, Giorgio
Passarelli, Francesca
Perez, Marie
Tartaglione, Tommaso
Di Lella, Giovanni
Pallotta, Sabatino
Mazzanti, Cinzia
Nudo, Maurizio
Fortes, Cristina
Abeni, Damiano
De Galitiis, Federica
Marchetti, Paolo
Ricci, Francesco
Caggiati, Alessio
Ziparo, Vincenzo
Elia, Maurizio
Russo, Giandomenico
D'Atri, Stefania
Failla, Cristina Maria
Panebianco, Annarita
Annessi, Giorgio
Passarelli, Francesca
Perez, Marie
Tartaglione, Tommaso
Di Lella, Giovanni
Pallotta, Sabatino
Mazzanti, Cinzia
Nudo, Maurizio
Fortes, Cristina
Abeni, Damiano
De Galitiis, Federica
Marchetti, Paolo
Source :
AboutOpen; Vol. 5 No. 1 (2019): January - September 2019; 39-47; AboutOpen; V. 5 N. 1 (2019): January - September 2019; 39-47; 2465-2628
Publication Year :
2019

Abstract

Introduction: The Integrated Care Pathway (ICP) represents a multidisciplinary outline of anticipated care, placed in an appropriate timeframe, to support patients with specific conditions or symptoms. The aim of this paper is to define the ICP for patients with melanoma referring to the “Istituto Dermopatico dell’Immacolata-IRCCS di Roma e Villa Paola” (“Center”). Methods and results: A multidisciplinary group (oncologists, dermatologists, surgeons, pathologists etc.) was defined as well as a facilitator to act as a link between all experts. The first step of ICP development was a review of current practice for patients with melanoma referring to the Center. This first step had the scope to define the multidisciplinary process map (a “picture” of the care plan) for patients with melanoma. The process map defined: i) the activities performed during delivery of care to the patients, ii) the responsibilities for these activities and iii) potential problem areas or opportunities for improvements. The process map formed the basis of the final ICP document. Conclusion: The adoption of melanoma ICP will allow the multidisciplinary group to ensure that clinical guidelines and available evidence are incorporated into everyday practice. (Oncology, HTA & Market Access)

Details

Database :
OAIster
Journal :
AboutOpen; Vol. 5 No. 1 (2019): January - September 2019; 39-47; AboutOpen; V. 5 N. 1 (2019): January - September 2019; 39-47; 2465-2628
Notes :
application/pdf, text/html, application/epub+zip, application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1367000127
Document Type :
Electronic Resource